FilingReader Intelligence
Eris Lifesciences faces $2m GST demand notice
August 22, 2025 at 11:49 AM UTC•By FilingReader AI
Eris Lifesciences received a GST demand notice for INR 16.8 crore ($2 million) plus 18% annual interest from November 2019, relating to alleged non-payment of import tax on services for acquiring "Zomelis" trademark rights from Novartis AG Switzerland.
The company is consulting tax advisors and plans to contest the notice, maintaining it complied with GST laws.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
Primary Source Document
BSE:ERIS•Bombay Stock Exchange
News Alerts
Get instant email alerts when Eris Lifesciences publishes news
Free account required • Unsubscribe anytime